We are live on ! Find out more
QC

Quantessence Capital Portfolio holdings

AUM $20.5M
1-Year Est. Return 71.02%
This Fund
S&P 500
This Quarter Est. Return
+14.43%
1 Year Est. Return
+71.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$340M
AUM Growth
-$60.2M
Cap. Flow
-$87.3M
Cap. Flow %
-25.71%
Top 10 Hldgs %
46.41%
Holding
483
New
151
Increased
11
Reduced
18
Closed
302

Sector Composition

Rank Sector Weight
1 Industrials 31.47%
2 Real Estate 13.23%
3 Healthcare 10.04%
4 Financials 9.26%
5 Consumer Discretionary 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BECN
476
DELISTED
Beacon Roofing Supply, Inc.
BECN
-87,500
Closed -$10.8M
PDCO
477
DELISTED
Patterson Companies, Inc.
PDCO
-327,668
Closed -$10.2M
LGTY
478
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
-300,000
Closed -$4.28M
NVRO
479
DELISTED
NEVRO CORP.
NVRO
-227,701
Closed -$1.33M
ITCI
480
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-229,788
Closed -$30.3M
VOXX
481
DELISTED
VOXX International Corporation Class A
VOXX
-48,744
Closed -$366K
SASR
482
DELISTED
Sandy Spring Bancorp Inc
SASR
-75,000
Closed -$2.1M
FBMS
483
DELISTED
The First Bancshares, Inc.
FBMS
-50,000
Closed -$1.69M

Similar funds

Quantessence Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Quantessence Capital held 483 positions worth $340M, down 15% from $400M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Quantessence Capital withdrew a net $87.3M in Q2 2025, closing 302 positions and reducing 18 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $30.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 11% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Quantessence Capital opened a new position in The AZEK Co worth $63.6M.

  • Quantessence Capital's largest Q2 2025 buy was The AZEK Co: 1,170,131 shares worth $63.6M.
  • Quantessence Capital added most to Merck in Q2 2025, an estimated $3.19M increase.
  • Quantessence Capital's biggest Q2 2025 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $1.84M.
  • Quantessence Capital fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $30.3M.
  • Quantessence Capital's ten largest holdings make up 46% of its $340M portfolio in Q2 2025.
  • Quantessence Capital opened 151 new positions and closed 302 in Q2 2025.
  • Quantessence Capital's portfolio value fell 15% quarter-over-quarter to $340M.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.